FORM 8-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

November 17, 2023

Period of Report

November 15, 2023

Accession Number

0001437749-23-032463

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →